5Lynch BA, Lambeng N, Marchettic C, et sl. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam [J].Proo Natl Acad Sei, 2004,101(26):9861- 9866.
6Carunchio J, Pieri M, Ciotti MT, et al. Modulation of AMPA receptors in cultured cortical neurons induced by theantiepileptic drug levetiracetam [J]. Epilepsia, 2007, 48 (4): 654- 662.
7Verrotti h, Ccrminara C, Coppola G, et al. Levetiracetamin juvenile myoclonic epilepsy:long-term efficacy in newlydiagnosed adolescents[J]. Dev Ivied Child Neurol, 2008, 50 (1): 119 - 132.
8Perry S, Itolt P, Benatar M. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age[J].J Child Neurol, 2008.
9Callenbach PM, Arts WF, Ten Houten R, et al.hdd-onlevetiracetam in children and adolescents with refractoryepilepsy:Resuits of an open-label multi-centre study[J], Eur J Paediatr Neurol, 2007.
10Alberto V, Caterina C, hngelika M, et al. Levetiracetam in absence epilepsy[J]. Developmental Medicine & ChildNeurology, 2008, 50:1 -4.
